{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:43:05Z","timestamp":1788864185020,"version":"build-2803163510"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10741-021-10134-5","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T18:03:16Z","timestamp":1624903396000},"page":"711-724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Left ventricular hypertrophy and sudden cardiac death"],"prefix":"10.1007","volume":"27","author":[{"given":"Grigorios","family":"Giamouzis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Dimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Xanthopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Skoularigis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-4016","authenticated-orcid":false,"given":"Filippos","family":"Triposkiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"10134_CR1","volume-title":"1985","author":"Death, W.H.O.S.G.o.S.C. and O. World Health, Sudden cardiac death : report of a WHO scientific group [meeting held in Geneva from 24 to 27","year":"1984","unstructured":"World Health Organization (1985)\u00a0Sudden cardiac death\u202f: report of a WHO scientific group [meeting held in Geneva from 24 to 27 October\u00a01984]. World Health Organization, Geneva"},{"issue":"13","key":"10134_CR2","first-page":"e210","volume":"138","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM et al (2018) 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 138(13):e210\u2013e271","journal-title":"Circulation"},{"issue":"13","key":"10134_CR3","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","volume":"375","author":"L Kober","year":"2016","unstructured":"Kober L et al (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375(13):1221\u20131230","journal-title":"N Engl J Med"},{"issue":"6","key":"10134_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00428-017-2221-0","volume":"471","author":"C Basso","year":"2017","unstructured":"Basso C et al (2017) Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology. Virchows Arch 471(6):691\u2013705","journal-title":"Virchows Arch"},{"issue":"6","key":"10134_CR5","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","volume":"47","author":"EC Stecker","year":"2006","unstructured":"Stecker EC et al (2006) Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 47(6):1161\u20131166","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10134_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/hrt.2004.042473","volume":"91","author":"T Kahan","year":"2005","unstructured":"Kahan T, Bergfeldt L (2005) Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart (British Cardiac Society) 91(2):250\u2013256","journal-title":"Heart (British Cardiac Society)"},{"issue":"3","key":"10134_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1067\/mhj.2001.113218","volume":"141","author":"BA Vakili","year":"2001","unstructured":"Vakili BA, Okin PM, Devereux RB (2001) Prognostic implications of left ventricular hypertrophy. Am Heart J 141(3):334\u2013341","journal-title":"Am Heart J"},{"issue":"5","key":"10134_CR8","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","volume":"32","author":"AW Haider","year":"1998","unstructured":"Haider AW et al (1998) Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 32(5):1454\u20131459","journal-title":"J Am Coll Cardiol"},{"key":"10134_CR9","doi-asserted-by":"crossref","unstructured":"Ferdinand KC, Maraboto C (2019)\u00a0Is electrocardiography-left ventricular hypertrophy an obsolete marker for determining heart failure risk with hypertension? J Am Heart Assoc 8(8): p. e012457","DOI":"10.1161\/JAHA.119.012457"},{"issue":"3","key":"10134_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16(3):233\u2013270","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10134_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12968-020-00683-3","volume":"22","author":"N Kawel-Boehm","year":"2020","unstructured":"Kawel-Boehm N et al (2020) Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson 22(1):87","journal-title":"J Cardiovasc Magn Reson"},{"issue":"7","key":"10134_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J (2018) Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol 15(7):387\u2013407","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10134_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jacc.2019.06.053","volume":"74","author":"F Triposkiadis","year":"2019","unstructured":"Triposkiadis F, Xanthopoulos A, Butler J (2019) Cardiovascular aging and heart failure: JACC review topic of the Week. J Am Coll Cardiol 74(6):804\u2013813","journal-title":"J Am Coll Cardiol"},{"key":"10134_CR14","doi-asserted-by":"crossref","unstructured":"Niederseer D et al (2020)\u00a0Role of echocardiography in screening and evaluation of athletes. Heart","DOI":"10.1136\/heartjnl-2020-317996"},{"key":"10134_CR15","doi-asserted-by":"crossref","unstructured":"D'Ascenzi F et al (2020)\u00a0Female athlete's heart: sex effects on electrical and structural remodeling. Circ Cardiovasc Imaging\u00a013(12): p. e011587","DOI":"10.1161\/CIRCIMAGING.120.011587"},{"issue":"5","key":"10134_CR16","doi-asserted-by":"publisher","first-page":"H587","DOI":"10.1152\/ajpheart.00588.2015","volume":"310","author":"A Olah","year":"2016","unstructured":"Olah A et al (2016) Physiological and pathological left ventricular hypertrophy of comparable degree is associated with characteristic differences of in vivo hemodynamics. Am J Physiol Heart Circ Physiol 310(5):H587\u2013H597","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"10134_CR17","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/clc.23466","volume":"43","author":"LA Malek","year":"2020","unstructured":"Malek LA, Bucciarelli-Ducci C (2020) Myocardial fibrosis in athletes: additional considerations. Clin Cardiol 43(11):1208","journal-title":"Clin Cardiol"},{"issue":"3","key":"10134_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/20961790.2019.1633761","volume":"4","author":"KS Cunningham","year":"2019","unstructured":"Cunningham KS, Spears DA, Care M (2019) Evaluation of cardiac hypertrophy in the setting of sudden cardiac death. Forensic sciences research 4(3):223\u2013240","journal-title":"Forensic sciences research"},{"issue":"5","key":"10134_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/eurheartj\/ehv548","volume":"37","author":"AM Katz","year":"2016","unstructured":"Katz AM, Rolett EL (2016) Heart failure: when form fails to follow function. Eur Heart J 37(5):449\u2013454","journal-title":"Eur Heart J"},{"issue":"8","key":"10134_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ejechocard\/jeq046","volume":"11","author":"VA Kuznetsov","year":"2010","unstructured":"Kuznetsov VA et al (2010) Asymmetric septal hypertrophy in patients with coronary artery disease. Eur J Echocardiogr 11(8):698\u2013702","journal-title":"Eur J Echocardiogr"},{"issue":"4","key":"10134_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/europace\/euaa012","volume":"22","author":"G Finocchiaro","year":"2020","unstructured":"Finocchiaro G et al (2020) Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy. Europace 22(4):632\u2013642","journal-title":"Europace"},{"issue":"4","key":"10134_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1136\/bjsm.2007.038158","volume":"42","author":"G Whyte","year":"2008","unstructured":"Whyte G et al (2008) Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause? Br J Sports Med 42(4):304\u2013305","journal-title":"Br J Sports Med"},{"issue":"25","key":"10134_CR23","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.117.033427","volume":"137","author":"ZH Tseng","year":"2018","unstructured":"Tseng ZH et al (2018) Prospective countywide surveillance and autopsy characterization of sudden cardiac death: POST SCD study. Circulation 137(25):2689\u20132700","journal-title":"Circulation"},{"issue":"1","key":"10134_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/CIRCIMAGING.111.964627","volume":"6","author":"GP Aurigemma","year":"2013","unstructured":"Aurigemma GP, de Simone G, Fitzgibbons TP (2013) Cardiac remodeling in obesity. Circ Cardiovasc Imaging 6(1):142\u2013152","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10134_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1053\/hj.1998.v136.90226","volume":"136","author":"WB Kannel","year":"1998","unstructured":"Kannel WB et al (1998) Sudden coronary death in women. Am Heart J 136(2):205\u2013212","journal-title":"Am Heart J"},{"issue":"6","key":"10134_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/heartjnl-2019-315437","volume":"106","author":"A Holkeri","year":"2020","unstructured":"Holkeri A et al (2020) Predicting sudden cardiac death in a general population using an electrocardiographic risk score. Heart 106(6):427\u2013433","journal-title":"Heart"},{"key":"10134_CR27","doi-asserted-by":"crossref","unstructured":"Konety SH et al (2016)\u00a0Echocardiographic predictors of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study. Circ Cardiovasc Imaging\u00a09(8)","DOI":"10.1161\/CIRCIMAGING.115.004431"},{"key":"10134_CR28","doi-asserted-by":"crossref","unstructured":"Laukkanen JA et al (2014)\u00a0Left ventricular mass and the risk of sudden cardiac death: a population-based study. J Am Heart Assoc\u00a03(6): p. e001285","DOI":"10.1161\/JAHA.114.001285"},{"issue":"5","key":"10134_CR29","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/HYPERTENSIONAHA.119.12684","volume":"73","author":"P Verdecchia","year":"2019","unstructured":"Verdecchia P et al (2019) Sudden cardiac death in hypertensive patients. Hypertension 73(5):1071\u20131078","journal-title":"Hypertension"},{"issue":"2","key":"10134_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/CIRCEP.112.977777","volume":"6","author":"PM Okin","year":"2013","unstructured":"Okin PM et al (2013) Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy. Circ Arrhythm Electrophysiol 6(2):243\u2013251","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"10134_CR31","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.amjcard.2008.06.036","volume":"102","author":"MP Turakhia","year":"2008","unstructured":"Turakhia MP, Schiller NB, Whooley MA (2008) Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol 102(9):1131\u20131135","journal-title":"Am J Cardiol"},{"issue":"20","key":"10134_CR32","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1001\/jama.1995.03520440046035","volume":"273","author":"Y Liao","year":"1995","unstructured":"Liao Y et al (1995) The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 273(20):1592\u20131597","journal-title":"JAMA"},{"issue":"36","key":"10134_CR33","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H et al (2017) 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38(36):2739\u20132791","journal-title":"Eur Heart J"},{"key":"10134_CR34","doi-asserted-by":"crossref","unstructured":"Prejean SP et al (2021)\u00a0Review of published cases of syncope and sudden death in patients with severe aortic stenosis documented by electrocardiography. Am J Cardiol","DOI":"10.1016\/j.amjcard.2021.02.023"},{"key":"10134_CR35","doi-asserted-by":"crossref","unstructured":"Taniguchi T et al (2018)\u00a0Sudden death in patients with severe aortic stenosis: observations from the current as registry. J Am Heart Assoc 7(11)","DOI":"10.1161\/JAHA.117.008397"},{"issue":"21","key":"10134_CR36","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1136\/heartjnl-2019-316493","volume":"106","author":"J Minners","year":"2020","unstructured":"Minners J et al (2020) Sudden cardiac death in asymptomatic patients with aortic stenosis. Heart 106(21):1646\u20131650","journal-title":"Heart"},{"issue":"24","key":"10134_CR37","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","volume":"342","author":"P Spirito","year":"2000","unstructured":"Spirito P et al (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342(24):1778\u20131785","journal-title":"N Engl J Med"},{"issue":"3","key":"10134_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","volume":"142","author":"A Miron","year":"2020","unstructured":"Miron A et al (2020) A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy. Circulation 142(3):217\u2013229","journal-title":"Circulation"},{"key":"10134_CR39","doi-asserted-by":"crossref","unstructured":"Gilstrap LG et al (2019)\u00a0Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service medicare beneficiaries in the United States. Circ Heart Fail 12(6): p. e005407","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407"},{"issue":"2","key":"10134_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","volume":"68","author":"MS Maurer","year":"2016","unstructured":"Maurer MS et al (2016) Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol 68(2):161\u2013172","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10134_CR41","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.19102\/icrm.2018.090301","volume":"9","author":"RM John","year":"2018","unstructured":"John RM (2018) Arrhythmias in cardiac amyloidosis. J Innov Card Rhythm Manag 9(3):3051\u20133057","journal-title":"J Innov Card Rhythm Manag"},{"issue":"18","key":"10134_CR42","doi-asserted-by":"publisher","first-page":"e012097","DOI":"10.1161\/JAHA.119.012097","volume":"8","author":"M Orini","year":"2019","unstructured":"Orini M et al (2019) Noninvasive mapping of the electrophysiological substrate in cardiac amyloidosis and its relationship to structural abnormalities. J Am Heart Assoc 8(18):e012097\u2013e012097","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10134_CR43","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0735-1097(97)00267-2","volume":"30","author":"J Reisinger","year":"1997","unstructured":"Reisinger J et al (1997) Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. J Am Coll Cardiol 30(4):1046\u20131051","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10134_CR44","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1540-8167.2005.00321.x","volume":"17","author":"H Mlcochova","year":"2006","unstructured":"Mlcochova H et al (2006) Catheter ablation of ventricular fibrillation storm in patients with infiltrative amyloidosis of the heart. J Cardiovasc Electrophysiol 17(4):426\u2013430","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"10134_CR45","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cjca.2019.12.002","volume":"36","author":"RM John","year":"2020","unstructured":"John RM, Stern DL (2020) Use of implantable electronic devices in patients with cardiac amyloidosis. Can J Cardiol 36(3):408\u2013415","journal-title":"Can J Cardiol"},{"issue":"9","key":"10134_CR46","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.3390\/ijms22094434","volume":"22","author":"O Azevedo","year":"2021","unstructured":"Azevedo O et al (2021) Fabry disease and the heart: a comprehensive review. Int J Mol Sci 22(9):4434","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10134_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.hrthm.2010.08.006","volume":"8","author":"H Higashi","year":"2011","unstructured":"Higashi H et al (2011) Endocardial and epicardial substrates of ventricular tachycardia in a patient with Fabry disease. Heart Rhythm 8(1):133\u2013136","journal-title":"Heart Rhythm"},{"issue":"7","key":"10134_CR48","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ejhf.1960","volume":"22","author":"A Linhart","year":"2020","unstructured":"Linhart A et al (2020) An expert consensus document on the management of cardiovascular manifestations of Fabry disease. Eur J Heart Fail 22(7):1076\u20131096","journal-title":"Eur J Heart Fail"},{"key":"10134_CR49","doi-asserted-by":"crossref","unstructured":"Qui\u00f1ones MA et al (2000)\u00a0Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 35(5): p. 1237\u201344","DOI":"10.1016\/S0735-1097(00)00511-8"},{"issue":"8","key":"10134_CR50","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.hrthm.2011.02.037","volume":"8","author":"K Reinier","year":"2011","unstructured":"Reinier K et al (2011) Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease. Heart Rhythm 8(8):1177\u20131182","journal-title":"Heart Rhythm"},{"key":"10134_CR51","doi-asserted-by":"crossref","unstructured":"Phan D et al (2016)\u00a0Left ventricular geometry and risk of sudden cardiac arrest in patients with severely reduced ejection fraction. J Am Heart Assoc 5(8)","DOI":"10.1161\/JAHA.116.003715"},{"issue":"7","key":"10134_CR52","first-page":"1146","volume":"19","author":"AL Aro","year":"2017","unstructured":"Aro AL et al (2017) Left-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction. Europace 19(7):1146\u20131152","journal-title":"Europace"},{"issue":"8","key":"10134_CR53","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jchf.2018.02.014","volume":"6","author":"M Vaduganathan","year":"2018","unstructured":"Vaduganathan M et al (2018) Sudden death in heart failure with preserved ejection fraction: a competing risks analysis from the TOPCAT trial. JACC Heart Fail 6(8):653\u2013661","journal-title":"JACC Heart Fail"},{"issue":"6","key":"10134_CR54","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/eurjhf\/hft062","volume":"15","author":"MM Chan","year":"2013","unstructured":"Chan MM, Lam CS (2013) How do patients with heart failure with preserved ejection fraction die? Eur J Heart Fail 15(6):604\u2013613","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10134_CR55","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jacc.2016.10.078","volume":"69","author":"M Vaduganathan","year":"2017","unstructured":"Vaduganathan M et al (2017) Mode of death in heart failure with preserved ejection fraction. J Am Coll Cardiol 69(5):556\u2013569","journal-title":"J Am Coll Cardiol"},{"key":"10134_CR56","doi-asserted-by":"crossref","unstructured":"Kitai T et al (2020)\u00a0Mode of death among Japanese adults with heart failure with preserved, midrange, and reduced ejection fraction. JAMA Netw Open 3(5): p. e204296","DOI":"10.1001\/jamanetworkopen.2020.4296"},{"issue":"1","key":"10134_CR57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12872-020-01361-z","volume":"20","author":"PD Yazdanfard","year":"2020","unstructured":"Yazdanfard PD et al (2020) Non-diagnostic autopsy findings in sudden unexplained death victims. BMC Cardiovasc Disord 20(1):58","journal-title":"BMC Cardiovasc Disord"},{"key":"10134_CR58","doi-asserted-by":"crossref","unstructured":"Smith DL et al (2018)\u00a0Pathoanatomic findings associated with duty-related cardiac death in US firefighters: a case-control study. J Am Heart Assoc 7(18): p. e009446","DOI":"10.1161\/JAHA.118.009446"},{"issue":"10","key":"10134_CR59","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.hrthm.2018.04.019","volume":"15","author":"M Dennis","year":"2018","unstructured":"Dennis M et al (2018) A 10-year review of sudden death during sporting activities. Heart Rhythm 15(10):1477\u20131483","journal-title":"Heart Rhythm"},{"issue":"8","key":"10134_CR60","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/0895-4356(96)00114-X","volume":"49","author":"R Manfredini","year":"1996","unstructured":"Manfredini R et al (1996) Out-of-hospital sudden death referring to an emergency department. J Clin Epidemiol 49(8):865\u2013868","journal-title":"J Clin Epidemiol"},{"key":"10134_CR61","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ahj.2018.11.006","volume":"209","author":"N Huynh","year":"2019","unstructured":"Huynh N et al (2019) Clinical and pathologic findings of aortic dissection at autopsy: review of 336 cases over nearly 6 decades. Am Heart J 209:108\u2013115","journal-title":"Am Heart J"},{"issue":"1","key":"10134_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ahj.2009.10.019","volume":"159","author":"AS Adabag","year":"2010","unstructured":"Adabag AS et al (2010) Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation. Am Heart J 159(1):33\u201339","journal-title":"Am Heart J"},{"issue":"16","key":"10134_CR63","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1212\/WNL.0000000000003238","volume":"87","author":"AS Kim","year":"2016","unstructured":"Kim AS et al (2016) Sudden neurologic death masquerading as out-of-hospital sudden cardiac death. Neurology 87(16):1669\u20131673","journal-title":"Neurology"},{"issue":"11","key":"10134_CR64","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy WC et al (2006) The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113(11):1424\u20131433","journal-title":"Circulation"},{"issue":"4","key":"10134_CR65","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.106.687103","volume":"116","author":"D Mozaffarian","year":"2007","unstructured":"Mozaffarian D et al (2007) Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation 116(4):392\u2013398","journal-title":"Circulation"},{"issue":"10","key":"10134_CR66","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.hrthm.2015.06.039","volume":"12","author":"R Shadman","year":"2015","unstructured":"Shadman R et al (2015) A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model. Heart Rhythm 12(10):2069\u20132077","journal-title":"Heart Rhythm"},{"issue":"4","key":"10134_CR67","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/europace\/euaa002","volume":"22","author":"R Fukuoka","year":"2020","unstructured":"Fukuoka R et al (2020) Prediction of sudden cardiac death in Japanese heart failure patients: international validation of the Seattle Proportional Risk Model. Europace 22(4):588\u2013597","journal-title":"Europace"},{"issue":"5","key":"10134_CR68","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jchf.2014.05.006","volume":"2","author":"WC Levy","year":"2014","unstructured":"Levy WC, Anand IS (2014) Heart failure risk prediction models: what have we learned? JACC Heart Fail 2(5):437\u2013439","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10134_CR69","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00063-005-1076-3","volume":"100","author":"H Kuhn","year":"2005","unstructured":"Kuhn H, Lawrenz T, Beer G (2005) Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy. Med Klin (Munich) 100(9):553\u2013561","journal-title":"Med Klin (Munich)"},{"issue":"6","key":"10134_CR70","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s12350-016-0595-z","volume":"23","author":"V Delgado","year":"2016","unstructured":"Delgado V, Bucciarelli-Ducci C, Bax JJ (2016) Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonance. J Nucl Cardiol 23(6):1399\u20131410","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"10134_CR71","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.amjcard.2014.07.015","volume":"114","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S et al (2014) Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. Am J Cardiol 114(7):1049\u20131052","journal-title":"Am J Cardiol"},{"key":"10134_CR72","doi-asserted-by":"crossref","unstructured":"Nadarajah R, Patel PA, Tayebjee MH (2021)\u00a0Is hypertensive left ventricular hypertrophy a cause of sustained ventricular arrhythmias in humans? J Hum Hypertens","DOI":"10.1038\/s41371-021-00503-w"},{"issue":"1","key":"10134_CR73","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/CIRCEP.112.974931","volume":"6","author":"SM Stevens","year":"2013","unstructured":"Stevens SM, Reinier K, Chugh SS (2013) Increased left ventricular mass as a predictor of sudden cardiac death: is it time to put it to the test? Circ Arrhythm Electrophysiol 6(1):212\u2013217","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"10134_CR74","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ncpcardio0241","volume":"2","author":"RD Winslow","year":"2005","unstructured":"Winslow RD, Mehta D, Fuster V (2005) Sudden cardiac death: mechanisms, therapies and challenges. Nat Clin Pract Cardiovasc Med 2(7):352\u2013360","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"12 Pt 3","key":"10134_CR75","doi-asserted-by":"publisher","first-page":"181s","DOI":"10.1016\/S0895-7061(99)00106-5","volume":"12","author":"FH Messerli","year":"1999","unstructured":"Messerli FH (1999) Hypertension and sudden cardiac death. Am J Hypertens 12(12 Pt 3):181s\u2013188s","journal-title":"Am J Hypertens"},{"key":"10134_CR76","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijcard.2017.03.002","volume":"237","author":"M Shenasa","year":"2017","unstructured":"Shenasa M, Shenasa H (2017) Hypertension, left ventricular hypertrophy, and sudden cardiac death. Int J Cardiol 237:60\u201363","journal-title":"Int J Cardiol"},{"issue":"6","key":"10134_CR77","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11886-002-0105-6","volume":"4","author":"LL Tin","year":"2002","unstructured":"Tin LL, Beevers DG, Lip GY (2002) Hypertension, left ventricular hypertrophy, and sudden death. Curr Cardiol Rep 4(6):449\u2013457","journal-title":"Curr Cardiol Rep"},{"issue":"Suppl 1","key":"10134_CR78","first-page":"107","volume":"88","author":"KT Weber","year":"1993","unstructured":"Weber KT et al (1993) Myocardial fibrosis: role of angiotensin II and aldosterone. Basic Res Cardiol 88(Suppl 1):107\u2013124","journal-title":"Basic Res Cardiol"},{"issue":"11","key":"10134_CR79","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/cvr\/23.11.983","volume":"23","author":"DA Sideris","year":"1989","unstructured":"Sideris DA et al (1989) Arrhythmogenic effect of high blood pressure: some observations on its mechanism. Cardiovasc Res 23(11):983\u2013992","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10134_CR80","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4330\/wjc.v2.i9.289","volume":"2","author":"KI Stroumpoulis","year":"2010","unstructured":"Stroumpoulis KI, Pantazopoulos IN, Xanthos TT (2010) Hypertrophic cardiomyopathy and sudden cardiac death. World J Cardiol 2(9):289\u2013298","journal-title":"World J Cardiol"},{"issue":"12","key":"10134_CR81","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1161\/CIRCRESAHA.116.304691","volume":"116","author":"KC Yang","year":"2015","unstructured":"Yang KC et al (2015) Mechanisms of sudden cardiac death: oxidants and metabolism. Circ Res 116(12):1937\u20131955","journal-title":"Circ Res"},{"issue":"9","key":"10134_CR82","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1172\/JCI26381","volume":"115","author":"M Rubart","year":"2005","unstructured":"Rubart M, Zipes DP (2005) Mechanisms of sudden cardiac death. J Clin Invest 115(9):2305\u20132315","journal-title":"J Clin Invest"},{"issue":"1","key":"10134_CR83","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2013.02.047","volume":"153","author":"L Zhang","year":"2013","unstructured":"Zhang L et al (2013) Phospholipase C\u03b5 hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy. Cell 153(1):216\u2013227","journal-title":"Cell"},{"issue":"3","key":"10134_CR84","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm1000","volume":"10","author":"JC Braz","year":"2004","unstructured":"Braz JC et al (2004) PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 10(3):248\u2013254","journal-title":"Nat Med"},{"issue":"17","key":"10134_CR85","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1042\/CS20160036","volume":"130","author":"AC Newton","year":"2016","unstructured":"Newton AC, Antal CE, Steinberg SF (2016) Protein kinase C mechanisms that contribute to cardiac remodelling. Clin Sci (Lond) 130(17):1499\u20131510","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10134_CR86","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1152\/physrev.00015.2014","volume":"95","author":"PY Sato","year":"2015","unstructured":"Sato PY et al (2015) The evolving impact of g protein-coupled receptor kinases in cardiac health and disease. Physiol Rev 95(2):377\u2013404","journal-title":"Physiol Rev"},{"issue":"8","key":"10134_CR87","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1161\/CIRCRESAHA.107.164947","volume":"102","author":"M M\u00e9trich","year":"2008","unstructured":"M\u00e9trich M et al (2008) Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res 102(8):959\u2013965","journal-title":"Circ Res"},{"issue":"12","key":"10134_CR88","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/01.RES.0000194325.31359.86","volume":"97","author":"E Morel","year":"2005","unstructured":"Morel E et al (2005) cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ Res 97(12):1296\u20131304","journal-title":"Circ Res"},{"key":"10134_CR89","doi-asserted-by":"crossref","unstructured":"Pereira L et al (2015)\u00a0Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2 distribution and function in cardiomyocytes. Proc Natl Acad Sci USA\u00a0112(13): p. 3991\u20136","DOI":"10.1073\/pnas.1416163112"},{"issue":"2","key":"10134_CR90","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1161\/CIRCRESAHA.110.225888","volume":"108","author":"P Eder","year":"2011","unstructured":"Eder P, Molkentin JD (2011) TRPC channels as effectors of cardiac hypertrophy. Circ Res 108(2):265\u2013272","journal-title":"Circ Res"},{"issue":"2","key":"10134_CR91","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/CIRCRESAHA.117.311094","volume":"121","author":"CD Troupes","year":"2017","unstructured":"Troupes CD et al (2017) Role of STIM1 (Stromal Interaction Molecule 1) in hypertrophy-related contractile dysfunction. Circ Res 121(2):125\u2013136","journal-title":"Circ Res"},{"issue":"48","key":"10134_CR92","doi-asserted-by":"publisher","first-page":"18255","DOI":"10.1073\/pnas.0608791103","volume":"103","author":"E van Rooij","year":"2006","unstructured":"van Rooij E et al (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103(48):18255\u201318260","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10134_CR93","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10557-011-6289-5","volume":"25","author":"VK Topkara","year":"2011","unstructured":"Topkara VK, Mann DL (2011) Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther 25(2):171\u2013182","journal-title":"Cardiovasc Drugs Ther"},{"key":"10134_CR94","doi-asserted-by":"crossref","unstructured":"Kakimoto Y et al (2018)\u00a0Overexpression of miR-221 in sudden death with cardiac hypertrophy patients. Heliyon\u00a04(6): p. e00639","DOI":"10.1016\/j.heliyon.2018.e00639"},{"issue":"5","key":"10134_CR95","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2217\/pme.10.44","volume":"7","author":"VK Topkara","year":"2010","unstructured":"Topkara VK, Mann DL (2010) Clinical applications of miRNAs in cardiac remodeling and heart failure. Per Med 7(5):531\u2013548","journal-title":"Per Med"},{"issue":"4","key":"10134_CR96","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nm1569","volume":"13","author":"B Yang","year":"2007","unstructured":"Yang B et al (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13(4):486\u2013491","journal-title":"Nat Med"},{"issue":"10","key":"10134_CR97","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.108.183087","volume":"103","author":"V Divakaran","year":"2008","unstructured":"Divakaran V, Mann DL (2008) The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 103(10):1072\u20131083","journal-title":"Circ Res"},{"issue":"22","key":"10134_CR98","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.110.976092","volume":"122","author":"GI Fishman","year":"2010","unstructured":"Fishman GI et al (2010) Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation 122(22):2335\u20132348","journal-title":"Circulation"},{"key":"10134_CR99","doi-asserted-by":"crossref","unstructured":"Desai RJ et al (2020)\u00a0Comparison of machine learning methods with traditional models for use of administrative claims with electronic medical records to predict heart failure outcomes. JAMA Netw Open\u00a03(1): p. e1918962","DOI":"10.1001\/jamanetworkopen.2019.18962"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10134-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-021-10134-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10134-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T01:25:51Z","timestamp":1666747551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-021-10134-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10134"],"URL":"https:\/\/doi.org\/10.1007\/s10741-021-10134-5","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"22 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"G.G. No disclosures, A.D. No disclosures, AX Honoraria from Novartis, J.S. No disclosures, F.T. Research support and honoraria from Amgen, Bayer, Boehringer Ingelheim, Elpen, Lilly, Menarini, Merck, Novartis, Sanofi, Servier, Vianex and WinMedica.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}